Table 1.
Estimated Direct Cost of Uterine Fibroids
| Range of Women Having Each Intervention
|
Cost Estimates
|
Estimate of Total Cost
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Medical Management
|
|||||||||
| Medications, inpatient admissions, outpatient visits | $5,563 (5) | - | $8,665 (6) | $3,271,956,332 | - | $5,096,441,060 | |||
|
Surgical Management
|
|||||||||
| Hysterectomy | 21.00% (5) | - | 52.90% (8) | $6,287 (7) | - | $11,538 (8) | $776,532,518 | - | $3,589,921,782 |
| Myomectomy | 1.00% (24) | - | 5.93% (25) | $6,805 (7) | - | $14,850 (7) | $40,027,010 | - | $517,938,300 |
| Uterine artery embolization | 0.20% (24) | - | 1.77% (25) | $6,805 (7) | - | $12,863 (8) | $8,002,680 | - | $133,916,693 |
| Endometrial ablation | 0.16% (5) | - | 2.43% (25) | $4,943(8) | - | $4,943 (8) | $4,651,363
|
- | $70,645,356
|
| Total Direct Costs | $4,101,169,903 | - | $9,408,863,191 | ||||||
Note: Total women seeking treatment for fibroids was calculated by number of women aged 25–54 (63,930,821) multiplied by baseline prevalence of 0.92%=588,164.
All costs are reported in 2010 dollars